Fanjun Cheng

545 total citations
27 papers, 338 citations indexed

About

Fanjun Cheng is a scholar working on Genetics, Hematology and Oncology. According to data from OpenAlex, Fanjun Cheng has authored 27 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 11 papers in Hematology and 10 papers in Oncology. Recurrent topics in Fanjun Cheng's work include Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Mesenchymal stem cell research (6 papers). Fanjun Cheng is often cited by papers focused on Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Mesenchymal stem cell research (6 papers). Fanjun Cheng collaborates with scholars based in China. Fanjun Cheng's co-authors include Xiaojian Zhu, Ping Zou, Zhaodong Zhong, Na Jin, Liling Zhang, Yong You, Weilong Chang, An‐Yuan Guo, Bin Fang and Zhichao Chen and has published in prestigious journals such as Cancer Research, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Fanjun Cheng

26 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fanjun Cheng China	10	172	98	83	69	66	27	338
Shihong Shao China	12	86 0.5×	69 0.7×	83 1.0×	68 1.0×	36 0.5×	27	368
Raquel Alves Portugal	13	196 1.1×	63 0.6×	111 1.3×	179 2.6×	63 1.0×	35	421
Irina Mantovani Italy	8	291 1.7×	98 1.0×	39 0.5×	74 1.1×	38 0.6×	10	381
Sheng-Fung Lin Taiwan	10	243 1.4×	50 0.5×	49 0.6×	72 1.0×	109 1.7×	23	380
Diederik van Bodegom United States	7	185 1.1×	101 1.0×	28 0.3×	40 0.6×	42 0.6×	10	360
Stephanie Nguyen Australia	7	106 0.6×	78 0.8×	52 0.6×	44 0.6×	38 0.6×	17	312
Elena Cesaro Italy	15	425 2.5×	62 0.6×	46 0.6×	60 0.9×	75 1.1×	27	570
Sen Zhang China	10	140 0.8×	62 0.6×	32 0.4×	70 1.0×	40 0.6×	33	364
Leandro F. Dalmazzo Brazil	7	206 1.2×	52 0.5×	31 0.4×	80 1.2×	78 1.2×	13	330
Durga Attili United States	11	199 1.2×	111 1.1×	28 0.3×	79 1.1×	111 1.7×	16	436

Countries citing papers authored by Fanjun Cheng

Since Specialization

Citations

This map shows the geographic impact of Fanjun Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanjun Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanjun Cheng more than expected).

Fields of papers citing papers by Fanjun Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanjun Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanjun Cheng. The network helps show where Fanjun Cheng may publish in the future.

Co-authorship network of co-authors of Fanjun Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Fanjun Cheng. A scholar is included among the top collaborators of Fanjun Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanjun Cheng. Fanjun Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Jing, et al.. (2025). Epstein-Barr virus: biology, pathogenesis and therapy of lymphomas. Discover Oncology. 16(1). 2154–2154.

Chen, Yilin, et al.. (2023). Successful treatment discontinuation in CML patients with full-dose and low-dose TKI: Results from real-world practice. Frontiers in Pharmacology. 14. 1101743–1101743. 5 indexed citations

Liu, Wen, Xiaoying Zhu, Ling Tang, et al.. (2022). ACSL1 promotes imatinib-induced chronic myeloid leukemia cell senescence by regulating SIRT1/p53/p21 pathway. Scientific Reports. 12(1). 17990–17990. 10 indexed citations

Chen, Yilin, et al.. (2021). Treatment-Free Remission in Chronic Myeloid Leukemia and New Approaches by Targeting Leukemia Stem Cells. Frontiers in Oncology. 11. 769730–769730. 13 indexed citations

Chen, Yilin, Yong Gao, Peng Sun, et al.. (2021). Mobile isolation wards in a fever clinic: a novel operation model during the COVID-19 pandemic. Epidemiology and Infection. 149. e61–e61. 2 indexed citations

Zhou, Shu, Xiaoying Zhu, Na Shen, et al.. (2019). T cells expressing CD26-specific chimeric antigen receptors exhibit extensive self-antigen-driven fratricide. Immunopharmacology and Immunotoxicology. 41(4). 490–496. 9 indexed citations

Shen, Na, Qing Li, Yong You, et al.. (2019). <p>Tumor necrosis factor α knockout impaired tumorigenesis in chronic myeloid leukemia cells partly by metabolism modification and miRNA regulation</p>. OncoTargets and Therapy. Volume 12. 2355–2364. 9 indexed citations

Shen, Na, Yong You, Zhaodong Zhong, et al.. (2019). Monitoring and Analysis of Chinese Chronic Myeloid Leukemia Patients Who Have Stopped Tyrosine Kinase Inhibitor Therapy. Current Medical Science. 39(2). 211–216. 2 indexed citations

Zhou, Shu, Xiaoying Zhu, Wen Liu, et al.. (2019). Comparison of chronic myeloid leukemia stem cells and hematopoietic stem cells by global proteomic analysis. Biochemical and Biophysical Research Communications. 522(2). 362–367. 9 indexed citations

10.

Zhang, Hongmei, Qing Li, Xiaojian Zhu, et al.. (2016). miR-146b-5p within BCR-ABL1–Positive Microvesicles Promotes Leukemic Transformation of Hematopoietic Cells. Cancer Research. 76(10). 2901–2911. 81 indexed citations

11.

Chang, Weilong, et al.. (2016). Estrogen-induced SDF-1α production promotes the progression of ER-negative breast cancer via the accumulation of MDSCs in the tumor microenvironment. Scientific Reports. 6(1). 39541–39541. 48 indexed citations

12.

Li, Qing, Zhaodong Zhong, Chen Zeng, et al.. (2016). A clinical observation of Chinese chronic myelogenous leukemia patients after discontinuation of tyrosine kinase inhibitors. Oncotarget. 7(36). 58234–58243. 6 indexed citations

13.

Xiong, Bei, et al.. (2014). MDR1 C3435T polymorphism and childhood acute lymphoblastic leukemia susceptibility: An updated meta-analysis. Biomedicine & Pharmacotherapy. 69. 76–81. 10 indexed citations

14.

Chen, Long, et al.. (2010). Effect of Recombinant Human Erythropoietin On the Stemness of Bone Marrow-derived Mesenchymal Stem Cells in vitro. International Journal of Stem Cells. 3(2). 175–182. 4 indexed citations

15.

Cheng, Fanjun, et al.. (2008). [Effects of different doses of thrombopoietin on proliferation of bone marrow mesenchymal stem cells in mice].. PubMed. 16(4). 859–62. 1 indexed citations

16.

Qingping, Gao, et al.. (2005). [Effects of HGF on GVHD and Th1/Th2-related cytokines in ALL mice after allo-BMT].. PubMed. 13(1). 35–8. 1 indexed citations

17.

Cheng, Fanjun, et al.. (2003). [The growth characteristics of mesenchymal stem/progenitor cells in human umbilical cord blood].. PubMed. 11(6). 565–8. 6 indexed citations

18.

Cheng, Fanjun, et al.. (2003). Induced differentiation of human cord blood mesenchymal stem/progenitor cells into cardiomyocyte-like cellsin vitro. Current Medical Science. 23(2). 154–157. 18 indexed citations

19.

Lin, Jing-ming, Wei He, Yilin Wu, et al.. (2000). [GC-MS analysis of essential oil components of Alpinia oxphylla].. PubMed. 23(8). 448–53. 1 indexed citations

20.

Lin, Jing-ming, et al.. (2000). [Analysis of essential oil from Amomum tsaoko by extraction of supercritical CO2 fluid].. PubMed. 23(3). 145–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact